BIO CELLX

Understand the user needs and tailor the solution towards a new user group that would never think of using a bioprinter in their drug discovery and cancer research workflows. Traditional bioprinters are for their purposes too complex, flexible, inconsistent and slow.

Develop a device that will produce 3D cell culture models with higher repeatability and throughput than existing bioprinters.

Design a complete user experience, in terms of all hardware and software touch-points.

Develop all internal electromechanical systems and package it into a product design that is easy to use and on brand.

Interviews with target users, to understand their pain-points and ensure the device fits into their existing workflows.

Develop user workflows and link them to hardware and software interactions.

Create concept designs through sketching and rapid prototyping. Multiple rounds of both sub-system and full-scale prototypes to test and verify all design choices.

Testing and verification of usability and performance.

A deep understanding of a completely new group of target users.

A device that will reliably print a broad set of standardized 3D cell culture models in a repeatable, accurate and quick manner.

An interaction design adapted to the users’ workflows and addressing their biggest pain-points. Enabling setup of larger batch studies with increased sample consistency and use efficiency by automating more tasks, using pre-validated setups and requiring fewer user interactions.

A complete on-brand product experience throughout hardware and software.

Plan and perform research of both users and technologies.

Leading the pre-study, developing early concepts, proof of concept for sub-systems and design of first three full system prototypes.

Mapping of user flows, and creation of navigation architecture, layout and design. Iterating from early drafts, through wireframes and detailed prototypes.

Design of all user touch-points in final released software and hardware designs, and usability evaluations of them.

Two inventions, both patented. Source 1, source 2.